0000000000774789

AUTHOR

Dan Cristian Vodnar

showing 4 related works from this author

Gut microbiota and aging-A focus on centenarians.

2020

Gut microbiota (GM) is a dynamic organ throughout the lifespan. Aging is a complex process that comprises a plethora of mechanisms such as senescence, immunosenescence and inflammaging, representing important pathways of age-related diseases. GM structure could both influence and be influenced by aging occurring changes within the host. A unique category of long living individuals exists, namely centenarians that have the outstanding capacity to adapt to various challenges. Longevity seems to be associated with certain GM which, among other factors, might render individuals more resistant to age-related diseases and subsequently to long living. Diet, prebiotics, probiotics and synbiotics ma…

0301 basic medicineSenescenceAgingSynbioticsmedia_common.quotation_subjectLongevitySynbioticsGut microbiotaBiologyGut flora03 medical and health sciences0302 clinical medicineCentenariansHumansAging Centenarians Gut microbiota Prebiotics Probiotics Synbiotics Aged 80 and over Aging Gastrointestinal Microbiome Humans Longevity Prebiotics Probiotics SynbioticsMolecular Biologymedia_commonAged 80 and overProbioticsLongevityImmunosenescencebiology.organism_classificationGastrointestinal Microbiome030104 developmental biologyPrebioticsImmunologyMolecular Medicine030217 neurology & neurosurgery
researchProduct

Gut Microbiota, Obesity and Bariatric Surgery: Current Knowledge and Future Perspectives.

2019

Background::There is an urgent need for a better understanding and management of obesity and obesity- associated diseases. It is known that obesity is associated with structural and functional changes in the microbiome.Methods::The purpose of this review is to present current evidence from animal and human studies, demonstrating the effects and the potential efficacy of microbiota modulation in improving obesity and associated metabolic dysfunctions.Results::This review discusses possible mechanisms linking gut microbiota dysbiosis and obesity, since there is a dual interaction between the two of them. Furthermore, comments on bariatric surgery, as a favourable model to understand the under…

medicine.medical_specialtyBariatric Surgery030209 endocrinology & metabolismGut floraManagement of obesity03 medical and health sciencesTherapeutic approach0302 clinical medicineDrug DiscoverymedicineAnimalsHumansMicrobiomeObesity030304 developmental biologyAdiposityPharmacologyInflammation0303 health sciencesbiologyHuman studiesbusiness.industryAnimalMicrobiotamedicine.diseasebiology.organism_classificationObesitySurgeryDysbiosiGastrointestinal MicrobiomeObesity-associated diseaseDysbiosisbusinessDysbiosisHumanCurrent pharmaceutical design
researchProduct

A Novel Series of Acylhydrazones as Potential Anti-Candida Agents: Design, Synthesis, Biological Evaluation and In Silico Studies

2019

In the context of an increased incidence of invasive fungal diseases, there is an imperative need of new antifungal drugs with improved activity and safety profiles. A novel series of acylhydrazones bearing a 1,4-phenylene-bisthiazole scaffold was designed based on an analysis of structures known to possess anti-Candida activity obtained from a literature review. Nine final compounds were synthesized and evaluated in vitro for their inhibitory activity against various strains of Candida spp. The anti-Candida activity assay revealed that some of the new compounds are as active as fluconazole against most of the tested strains. A molecular docking study was conducted in order to evaluate the …

Antifungal AgentsMolecular modelIn silicoPharmaceutical ScienceContext (language use)anti-CandidaMicrobial Sensitivity Tests01 natural sciencesArticleAnalytical Chemistrylcsh:QD241-44103 medical and health scienceschemistry.chemical_compoundStructure-Activity Relationshiplcsh:Organic chemistryDrug DiscoverymedicinePhysical and Theoretical ChemistryFluconazole030304 developmental biologyCandida0303 health sciencesMolecular Structure010405 organic chemistrymolecular modelingLanosterolOrganic Chemistryanti-<i>Candida</i>HydrazonesBiological activityIn vitro0104 chemical sciencesMolecular Docking Simulationlanosterol 14α-demethylaseADMETchemistryBiochemistryDesign synthesisChemistry (miscellaneous)Drug DesignMolecular MedicinethiazoleFluconazoleacylhydrazonemedicine.drugProtein BindingMolecules
researchProduct

Design and Synthesis of Novel 1,3-Thiazole and 2-Hydrazinyl-1,3-Thiazole Derivatives as Anti-Candida Agents: In Vitro Antifungal Screening, Molecular…

2019

In the context of there being a limited number of clinically approved drugs for the treatment of Candida sp.-based infections, along with the rapid development of resistance to the existing antifungals, two novel series of 4-phenyl-1,3-thiazole and 2-hydrazinyl-4-phenyl-1,3-thiazole derivatives were synthesized and tested in vitro for their anti-Candida potential. Two compounds (7a and 7e) showed promising inhibitory activity against the pathogenic C. albicans strain, exhibiting substantially lower MIC values (7.81 &mu

Pharmaceutical Sciencefluorescence quenchingContext (language use)01 natural sciencesAnalytical Chemistrylcsh:QD241-44103 medical and health scienceschemistry.chemical_compoundlcsh:Organic chemistryIn vivobovine serum albuminDrug DiscoverymedicinePhysical and Theoretical ChemistryBovine serum albuminThiazole030304 developmental biology13-thiazole0303 health sciencesbiology010405 organic chemistryLanosterolOrganic Chemistryanti-<i>Candida</i>Biological activitymolecular dockingIn vitro0104 chemical scienceschemistryBiochemistryChemistry (miscellaneous)biology.proteinMolecular MedicineFluconazolemedicine.drugMolecules
researchProduct